Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

By Johansson B.E.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 2073-2080

Elsevier

Access to resources Recommend Favorite

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

By Kilbourne E.D.   Couch R.B.   Kasel J.A.   Keitel W.A.   Cate T.R.   Quarles J.H.   Grajower B.   Pokorny B.A.   Johansson B.E.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1799-1803

Elsevier

Access to resources Recommend Favorite

Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice

By Olsen C.W.   McGregor M.W.   Dybdahl-Sissoko N.   Schram B.R.   Nelson K.M.   Lunn D.P.   Macklin M.D.   Swain W.F.   Hinshaw V.S.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1149-1156

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice

By Bertolotti-Ciarlet A.   Ciarlet M.   Crawford S.E.   Conner M.E.   Estes M.K.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3885-3900

Elsevier

Access to resources Recommend Favorite

Preparation and characterization of a purified influenza virus neuraminidase vaccine

By Hocart M.   Grajower B.   Donabedian A.   Pokorny B.   Whitaker C.   Kilbourne E.D.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1793-1798

Elsevier

Access to resources Recommend Favorite